Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Wetmore

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Stem Cells (Dayton, Ohio)|February 16, 2008
Gli1 induces G2/M arrest and apoptosis in hippocampal but not tumor-derived neural stem cellsKatherine E Galvin, Hong Ye, Derek J Erstad, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 14, 2021
Population Pharmacokinetics of Sunitinib and its Active Metabolite SU012662 in Pediatric Patients with Gastrointestinal Stromal Tumors or Other Solid TumorsErjian Wang, Steven G DuBois, Cynthia Wetmore, et al.
Pediatric Neurosurgery|March 30, 2012
Opticochiasmatic apoplexy in a five-year-oldBret Gene Ball, Cynthia Wetmore, Caterina Giannini, et al.
Journal of Neuro-Oncology|April 19, 2011
Therapeutic doses of cranial irradiation induce hippocampus-dependent cognitive deficits in young miceAmulya A Nageswara Rao, Hong Ye, Paul A Decker, et al.
Cancer|August 1, 2014
Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity?Cynthia Wetmore, Danielle Herington, Tong Lin, et al.
Cancer Research|June 8, 2011
Sequential activation of Snail1 and N-Myc modulates sonic hedgehog-induced transformation of neural cellsLeah E Colvin Wanshura, Katherine E Galvin, Hong Ye, et al.
Neuro-Oncology|February 18, 2015
Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 childrenCynthia Wetmore, James Boyett, Shaoyu Li, et al.
World Neurosurgery|April 16, 2011
Tardy spinal cord tumor following avulsive brachial plexus injury: coincidental or causal?Marie-Noëlle Hébert-Blouin, Allen T Bishop, Alexander Y Shin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 7, 2013
Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)Michael S Roberts, David C Turner, Thandranese S Owens, et al.
Pediatric Blood & Cancer|April 21, 2021
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515)Thomas Cash, Elizabeth Fox, Xiaowei Liu, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Stem Cells (Dayton, Ohio)|February 16, 2008
Gli1 induces G2/M arrest and apoptosis in hippocampal but not tumor-derived neural stem cellsKatherine E Galvin, Hong Ye, Derek J Erstad, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 14, 2021
Population Pharmacokinetics of Sunitinib and its Active Metabolite SU012662 in Pediatric Patients with Gastrointestinal Stromal Tumors or Other Solid TumorsErjian Wang, Steven G DuBois, Cynthia Wetmore, et al.
Pediatric Neurosurgery|March 30, 2012
Opticochiasmatic apoplexy in a five-year-oldBret Gene Ball, Cynthia Wetmore, Caterina Giannini, et al.
Journal of Neuro-Oncology|April 19, 2011
Therapeutic doses of cranial irradiation induce hippocampus-dependent cognitive deficits in young miceAmulya A Nageswara Rao, Hong Ye, Paul A Decker, et al.
Cancer|August 1, 2014
Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity?Cynthia Wetmore, Danielle Herington, Tong Lin, et al.
Cancer Research|June 8, 2011
Sequential activation of Snail1 and N-Myc modulates sonic hedgehog-induced transformation of neural cellsLeah E Colvin Wanshura, Katherine E Galvin, Hong Ye, et al.
Neuro-Oncology|February 18, 2015
Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 childrenCynthia Wetmore, James Boyett, Shaoyu Li, et al.
World Neurosurgery|April 16, 2011
Tardy spinal cord tumor following avulsive brachial plexus injury: coincidental or causal?Marie-Noëlle Hébert-Blouin, Allen T Bishop, Alexander Y Shin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 7, 2013
Determination of crenolanib in human serum and cerebrospinal fluid by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS)Michael S Roberts, David C Turner, Thandranese S Owens, et al.
Pediatric Blood & Cancer|April 21, 2021
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515)Thomas Cash, Elizabeth Fox, Xiaowei Liu, et al.
Pageof 6